You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IFN free

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)

Recruiting
  • Recurring Glioblastoma
  • Recombinant L-IFN adenovirus injection
  • Fujian, Fujian, China
    Binhai Hospital of Fujian Medical University
Jun 27, 2023

Action of Interferon in Treatment of Myeloproliferative

Recruiting
  • Myeloproliferative Neoplasm
    • Villejuif, Ile De France, France
      Inserm U1287
    Apr 28, 2023

    Microvesicles and Monocytes to Predict Mortality of Cirrhosis

    Active, not recruiting
    • Cirrhosis
      • Bobigny, France
      • +4 more
      Jan 19, 2023

      Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

      Completed
      • Stage III Malignant Melanoma of Skin AJCC V6
      • Stage IV Malignant Melanoma of Skin
      • TAPCells vaccine
      • Santiago, RM, Chile
        Faculty of Medicine, University of Chile
      Nov 21, 2023

      Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

      Recruiting
      • Head and Neck Cancer
      • +6 more
      • Recombinant L-IFN adenovirus injection
      • Shanghai, Shanghai, China
        Shanghai Fengxian District Central Hospital
      Jan 16, 2022

      Hepatitis C, Chronic, Opioid-Related Disorders Trial in Germany

      Completed
      • Hepatitis C, Chronic
      • Opioid-Related Disorders
        • Munich, Bavaria, Germany
        • +17 more
        Apr 27, 2021

        Against HCV Based on Direct-acting Antivirals in Real-life

        Completed
        • Chronic Hepatitis C Infection
        • Seville, Andalusia, Spain
          Valme University Hospital
        Jun 22, 2022

        Pleural Effusion, Malignant Trial (IFN-? and CIK cells, Tcm cells or CAR T cells)

        Not yet recruiting
        • Pleural Effusion, Malignant
        • IFN-γ and CIK cells, Tcm cells or CAR T cells
        • (no location specified)
        Mar 16, 2022

        Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)

        Not yet recruiting
        • Melanoma
        • Recombinant human interferon α1b
        • +2 more
        • Xi'an, Shaanxi, China
          Air Force Military Medical University/ Fourth Military Medical U
        Sep 13, 2022

        HCV Reinfection in HD Patients Achieving SVR

        Recruiting
        • Hepatitis C Virus Infection
        • +2 more
          • Douliu, Taiwan
          • +6 more
          Feb 22, 2021

          HIV Trial run by the NIAID (CD4-IgG, Zidovudine, Interferon alfa-n1)

          Completed
          • HIV Infections
          • Bethesda, Maryland
            Natl Inst of Allergy & Infect Dis / Cln Ctr
          Oct 26, 2021

          Dermatomyositis Trial in Paris (Baricitinib, Placebo)

          Not yet recruiting
          • Dermatomyositis
          • Paris, France
            Pitie-Salpêtrière hospital APHP
          Jun 7, 2022

          Malignant Pleural Mesothelioma Trial in Worldwide (rAd-IFN, Celecoxib Oral Product, Gemcitabine)

          Active, not recruiting
          • Malignant Pleural Mesothelioma
          • rAd-IFN
          • +2 more
          • Los Angeles, California
          • +41 more
          Oct 25, 2021

          Gastric Cancer Trial in Taiwan (AST-301, rhuGM-CSF)

          Not yet recruiting
          • Gastric Cancer
          • Kaohsiung, Taiwan
          • +5 more
          Mar 14, 2023

          HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR

          Recruiting
          • Hepatitis C Virus Infection
          • +2 more
            • Douliu, Taiwan
            • +6 more
            Feb 23, 2021

            Inflammation Gum Trial (Quercetin, scaling and root planing)

            Not yet recruiting
            • Inflammation Gum
            • (no location specified)
            Jun 23, 2023

            Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

            Completed
            Has Results
            • Acute Myeloid Leukemia
            • Ann Arbor, Michigan
              University of Michigan Comprehensive Cancer Center
            Oct 1, 2021

            CSF Single-cell Sequencing and Proteomics of Chronic

            Not yet recruiting
            • Chronic Postsurgical Pain
              • (no location specified)
              Nov 6, 2023

              Systemic Lupus Erythematosus, Interferon Deficiency Trial in Copenhagen (High Intensity Interval Training)

              Recruiting
              • Systemic Lupus Erythematosus
              • Interferon Deficiency
              • High Intensity Interval Training
              • Copenhagen, Denmark
                Center for Physical Activity Research
              Jul 26, 2022

              Polycythemia Vera Trial in London, Oxford (Ruxolitinib, Hydroxycarbamide, Interferon-Alpha)

              Recruiting
              • Polycythemia Vera
              • London, United Kingdom
              • +1 more
              Nov 29, 2021

              Myeloid Leukemia, MDS Trial (IFN-?)

              Not yet recruiting
              • Myeloid Leukemia
              • Myelodysplastic Syndromes
              • (no location specified)
              Nov 15, 2023

              Breast Cancer, Obesity, Weight Change, Body Trial (Very low calorie ketogenic diet (VLCKD), Group educational intervention

              Not yet recruiting
              • Breast Cancer
              • +3 more
              • Very low calorie ketogenic diet (VLCKD)
              • Group educational intervention program (IGOBE)
              • (no location specified)
              Sep 19, 2023

              SARS-CoV2 COVID-19 Trial in Randwick, Adelaide, Perth (COVIGEN C19 0.8 mg ID or Placebo ID, COVIGEN C19 2.0 mg IM or Placebo IM,

              Active, not recruiting
              • SARS-CoV2 COVID-19
              • COVIGEN C19 0.8 mg ID or Placebo ID
              • +3 more
              • Randwick, New South Wales, Australia
              • +2 more
              Nov 17, 2022

              Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

              Not yet recruiting
              • Liver Metastasis Colon Cancer
              • IRE plus checkpoint inhibitor
              • IRE plus Checkpoint Inhibitor plus CpG-ODN
              • (no location specified)
              Sep 13, 2023

              Melanoma Trial in Boulogne-Billancourt (venous puncture, tumoral biopsy)

              Recruiting
              • Melanoma
              • venous puncture
              • tumoral biopsy
              • Boulogne-Billancourt, France
                Dermato-oncology department, Ambroise Paré hospital, APHP
              Feb 9, 2022